Long-term follow-up after ICM-203 or placebo treatment
Part of Bones, joints & muscles clinical trials.
This study checks on people who previously received ICM-203 or a matching placebo. It helps researchers understand the longer-term safety and effects of the treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously received ICM-203 (the study medicine) or a matching placebo
- You must be able and willing to take part in long-term follow-up checks
- There are no other listed health or condition exclusions for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.
This follow-up study checks on people who took part earlier in the Jointstem study done during knee arthroscopy. It helps researchers understand what happens over time after the treatment.
This study follows patients who already took part in a previous trial for a knee implant (MP01). It checks how well the implant is working over 10 years compared to standard knee surgery.
This trial tests a new medicine called BBM-A101 for people with moderate knee osteoarthritis. It aims to see if it is safe and helps reduce pain and improve function.
This trial follows people who already have (or are receiving) a specific partial knee implant to see how they do over time using questionnaires after surgery. It may help improve care for future patients with knee arthritis who get this type of implant.
This study follows people after they get a total knee replacement using the Multigen Plus system, sometimes with special cone pieces. It looks at how well the implant performs over time and whether results meet expectations.
Hear when a new Osteoarthritis, Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.